Penile sonographic and clinical characteristics in men with peyronie's disease

Journal of Sexual Medicine

Volumn 6, Issue 10, 2009, Pages 2858-2867

  Smith, James F ^a   Brant, William O ^b   Fradet, Vincent ^a   Shindel, Alan W ^a   Vittinghoff, Eric ^a   Chi, Thomas ^a   Huang, Yun Ching ^a   Davis, Cole B ^a   Conti, Simon ^a   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Calcification; Intracavernosal fibrosis; Peyronie's disease; Septal fibrosis; Tunical thickening; Ultrasound

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCIFICATION; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DEFORMITY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PENIS DEFORMITY; PEYRONIE DISEASE; PLEURAL FIBROSIS; PREVALENCE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SKINFOLD; TUNICAL THICKENING; AGE; CALCINOSIS; FIBROSIS; HEALTH STATUS; MIDDLE AGED; PATHOLOGY; PENILE INDURATION; PENIS; QUESTIONNAIRE; RISK; STATISTICAL MODEL; TUNICA MEDIA; UNITED STATES;

ADULT; AGE FACTORS; AGED; CALCINOSIS; CALIFORNIA; CROSS-SECTIONAL STUDIES; FIBROSIS; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PENILE INDURATION; PENIS; PREVALENCE; QUESTIONNAIRES; TUNICA MEDIA;

EID: 70649094118     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01438.x     Document Type: Article

References (32)

1. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004, 171:2350-3.
2. Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001, 13:291-3.
3. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001, 88:727-30.
4. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997, 158:1391-4.
5. Brock G, Hsu GL, Nunes L, von Heyden B, Lue TF. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 1997, 157:276-81.
6. Husain J, Lynn NN, Jones DK, Collins GN, O'Reilly PH. Extracorporeal shock wave therapy in the management of Peyronie's disease: Initial experience. BJU Int 2000, 86:466-8.
7. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF. Is colchicine effective in Peyronie's disease? A pilot study. Urology 1994, 44:291-5.
8. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. BJU Int 2002, 89:895-900.
9. Di Stasi SM, Giannantoni A, Stephen RL, Capelli G, Giurioli A, Jannini EA, Vespasiani G. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol 2004, 171:1605-8.
10. Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study. Urology 2006, 67:1038-42.
11. Montorsi F, Salonia A, Guazzoni G, Barbieri L, Colombo R, Brausi M, Scattoni V, Rigatti P, Pizzini G. Transdermal electromotive multi-drug administration for Peyronie's disease: Preliminary results. J Androl 2000, 21:85-90.
12. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study. Urology 1998, 51:620-6.
13. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie's disease: A randomized double-blind, placebo-controlled study. Int J Impot Res 2004, 16:238-43.
14. Levine LA, Coogan CL. Penile vascular assessment using color duplex sonography in men with Peyronie's disease. J Urol 1996, 155:1270-3.
15. Lopez JA, Jarow JP. Duplex ultrasound findings in men with Peyronie's disease. Urol Radiol 1991, 12:199-202.
16. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J Urol 1993, 149:53-5.
17. Dang G, Matern R, Bivalacqua TJ, Sikka S, Hellstrom WJ. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease. South Med J 2004, 97:42-6.
18. Brant WO, Bella AJ, Garcia MM, Tantiwongse K, Dean RC, Lue TF. Isolated septal fibrosis or hematoma-Atypical Peyronie's disease?. J Urol 2007, 177:179-82. discussion 83
19. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: A preliminary report. BJU Int 2001, 88:63-7.
20. Weidner W, Hauck EW, Schnitker J. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: A prospective, placebo-controlled, randomized study. Eur Urol 2005, 47:530-5. discussion 35-6
21. Di Stasi SM, Giannantoni A, Capelli G, Jannini EA, Virgili G, Storti L, Vespasiani G. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. BJU Int 2003, 91:825-9.
22. Muralidhar S, Gulati M, Kumar B, Sharma SK, Suman K, Roy PB. An ultrasonographic study of Peyronie's disease. Australas Radiol 1996, 40:106-8.
23. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol 2003, 58:514-23.
24. Prando D. New sonographic aspects of Peyronie disease. J Ultrasound Med 2009, 28:217-32.
25. Hamm B, Friedrich M, Kelami A. Ultrasound imaging in Peyronie disease. Urology 1986, 28:540-5.
26. Andresen R, Wegner HE, Banzer D, Miller K. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease. Acta Radiol 1996, 37:352-6.
27. Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D. The natural history of Peyronie's disease: An ultrasonography-based study. Eur Urol 2008, 53:644-50.
28. Bella AJ, Sener A, Foell K, Brock GB. Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: An atypical form of Peyronie's disease. J Sex Med 2007, 4:226-30.
29. Bertolotto M, Perrone R, Bucci S, Zappetti R, Coss M. Comparison of conventional ultrasound and real-time spatial compound imaging in evaluation of patients with severe Peyronie's disease. Acta Radiol 2008, 49:596-601.
30. Iacono F, Barra S, De Rosa G, Boscaino A, Lotti T. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol 1993, 150:1806-9.
31. Somers KD, Dawson DM. Fibrin deposition in Peyronie's disease plaque. J Urol 1997, 157:311-5.
32. Zargooshi J. Trauma as the cause of Peyronie's disease: Penile fracture as a model of trauma. J Urol 2004, 172:186-8.